Anika Therapeutics(CH:AKP)
CH:AKP
Anika Therapeutics earnings date
Anika Therapeutics (AKP) Q2 2026 Earnings Report
0 Followers
CH:AKP Q2 2026 EPS Results
- Actual EPS
- CHF 0.35
- Consensus EPS
- CHF 0.03
- Beat/Miss
- Beat by +CHF 0.33
- One Year Ago EPS
- -CHF 0.11
CH:AKP Q2 2026 Revenue Results
- Actual Revenue
- CHF 27.24M
- Expected Revenue
- CHF 24.40M
- Beat/Miss
- Beat by +CHF 2.84M
- YoY Revenue Growth
- +15.56%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 07/29/2026
- Time
- Before Open
- Conference Call
- Wednesday, July 29, 2026
CH:AKP Upcoming Earnings
Anika Therapeutics's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
CH:AKP Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:AKP Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | 0.11- | 0.26 | ― | ― |
| Nov 06, 2026 | 2026 (Q3) | 0.350.24 | 0.03 | 625.00% (+0.21) | |
| Jul 29, 2026 | 2026 (Q2) | 0.030.35 | -0.11 | 423.08% (+0.46) | |
| Apr 29, 2026 | 2026 (Q1) | 0.000.23 | -0.05 | 550.00% (+0.28) | |
| Feb 26, 2026 | 2025 (Q4) | -0.100.26 | -0.03 | 1133.33% (+0.28) | |
| Nov 05, 2025 | 2025 (Q3) | -0.150.03 | -0.21 | 116.00% (+0.24) | |
| Jul 30, 2025 | 2025 (Q2) | -0.22-0.11 | 0.14 | -176.47% (-0.25) | |
| May 09, 2025 | 2025 (Q1) | -0.08-0.05 | 0.08 | -166.67% (-0.13) | |
| Mar 12, 2025 | 2024 (Q4) | -0.19-0.03 | 0.04 | -160.00% (-0.07) | |
| Oct 31, 2024 | 2024 (Q3) | 0.08-0.21 | 0 | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
